Thyroid Cancer Trial, Recruiting (NCT07302672)

Thyroid Cancer Trial, Recruiting NCT07302672 Sponsor: Ming-an Yu Condition: Thyroid Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07302672 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Thyroid Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 16 and 60 years old and are scheduled to have a thyroid thermal ablation procedure
You have been diagnosed with a type of thyroid cancer called papillary thyroid carcinoma (PTC)
You have no more than 3 areas in the thyroid that need to be treated
Your largest affected area is 2 cm or smaller, and scans show the cancer has not spread to lymph nodes or other parts of the body
You are able to stay awake and cooperate during the procedure, which is done under local anesthesia (you are awake but the area is numbed)
You own a smartphone and are able to use the WeChat messaging app

Who may not be able to join:

You have serious health conditions or memory/thinking difficulties that would make it hard to take part in the trial (confirm with trial site)
You have previously had thyroid surgery or a thermal ablation procedure on your thyroid
You are unwilling or unable to join a WeChat group or attend follow-up appointments after the procedure

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 84205756

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07302672

Sponsor: Ming-an Yu

Phase: Not Applicable

Status: Recruiting

Condition: Thyroid Cancer

Trial contact: 84205756

More information: https://clinicaltrials.gov/study/NCT07302672

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 16 and 60 years old and are scheduled to have a thyroid thermal ablation procedure
You have been diagnosed with a type of thyroid cancer called papillary thyroid carcinoma (PTC)
You have no more than 3 areas in the thyroid that need to be treated
Your largest affected area is 2 cm or smaller, and scans show the cancer has not spread to lymph nodes or other parts of the body
You are able to stay awake and cooperate during the procedure, which is done under local anesthesia (you are awake but the area is numbed)
You own a smartphone and are able to use the WeChat messaging app

Who may not be able to join:

You have serious health conditions or memory/thinking difficulties that would make it hard to take part in the trial (confirm with trial site)
You have previously had thyroid surgery or a thermal ablation procedure on your thyroid
You are unwilling or unable to join a WeChat group or attend follow-up appointments after the procedure

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Ming-an Yu

Registry

ClinicalTrials.gov

Start date

15 December 2025

Est. completion

30 June 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Change in emotion distress from baseline to post-procedure (HADS); Change in the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 scores from baseline to 3 months; Change in Thyroid Cancer-Specific Quality of Life Questionnaire scores from baseline to 3 months

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov